Related Experiment Video
Updated: Jul 8, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Caspase-2 is required for cell death induced by cytoskeletal disruption
Abstract:
Caspase-2 is one of the most conserved caspases, yet its biological function remains a matter of controversy. In the present article we analysed mouse embryonic fibroblasts (MEFs) from caspase-2 knockout mice for their sensitivity to various apoptosis inducing agents. We found that cell death induced by drugs that disrupt cytoskeleton is significantly inhibited in Casp2(-/-) MEFs. These drugs included zoledronic acid, vincristine, cytochalasin D and paclitaxel. We demonstrate that MEFs lacking Casp2 show clonogenic survival following drug treatment, whereas all Casp2(+/+) MEFs die, indicating that caspase-2 is required for apoptosis induced by cytoskeletal disruption. We further found that caspase-2 mediates apoptosis via Piddosome, Bid and Bax activation, and cytochrome c release. In the absence of caspase-2, Bid and Bax activation, and cytochrome c release are significantly delayed following drug treatment. Our data provide strong support for a context-dependent function of caspase-2 in apoptosis.
Insights
Caspase-2 (cell death protease) is crucial for apoptosis induced by cytoskeletal disruption. Its absence in mouse cells promotes survival against specific drug treatments, revealing a context-dependent role.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Caspase-2 is a highly conserved cysteine protease.
- Its precise biological role in apoptosis remains debated.
- Understanding caspase-2 function is key to cell death research.
Purpose of the Study:
- To investigate the role of caspase-2 in apoptosis.
- To analyze the sensitivity of caspase-2-deficient cells to apoptosis-inducing agents.
- To elucidate the signaling pathways regulated by caspase-2.
Main Methods:
- Utilized mouse embryonic fibroblasts (MEFs) from caspase-2 knockout (Casp2(-/-)) and wild-type (Casp2(+/+)) mice.
- Assessed cellular sensitivity to apoptosis-inducing drugs targeting the cytoskeleton (e.g., zoledronic acid, vincristine, cytochalasin D, paclitaxel).
- Analyzed key apoptotic markers including Piddosome, Bid, Bax activation, and cytochrome c release.
Main Results:
- Caspase-2 deficiency significantly inhibited cell death induced by cytoskeletal disruptors.
- Casp2(-/-) MEFs exhibited clonogenic survival, while Casp2(+/+) MEFs underwent apoptosis.
- Caspase-2 mediates apoptosis through Piddosome, Bid, and Bax activation, and cytochrome c release, with delayed kinetics in its absence.
Conclusions:
- Caspase-2 is essential for mediating apoptosis triggered by cytoskeletal disruption.
- The absence of caspase-2 confers resistance to specific apoptosis-inducing drugs.
- These findings highlight a context-dependent function of caspase-2 in regulating programmed cell death.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy

